Study on the safety and efficacy of the treatment of polidocanol injection for vascular lesions in the small bowel.

Study on the safety and efficacy of the treatment of polidocanol injection for vascular lesions in the small bowel. - Study on the safety and efficacy of polidocanol injection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009712

Enrollment

Registered

2013-01-07

Start date

2013-01-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular lesions in the small bowel

Interventions

Polidocanol injection for the treatment of vascular lesions in the small bowel

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with comfirmed vascular lesion in the small bowel and having at least 1 of following conditions; overt gastrointestinal bleeding, iron deficient anemia or positive fecal occult blood test.

Exclusion criteria

Exclusion criteria: 1. Patients with intestinal perforation 2. Patients with bleeding tendency 3. Patients administering anti conaglant drugs 4. Patients with severe hepatic diseases 5. Patients with severe renal diseases 6. Patients with severe respiratory diseases 7. Patients with severe cardiac diseases 8. Pregnant or feeding women

Design outcomes

Primary

Measure	Time frame
Complication rate Changes in hemoglobin concentration before and after polidocanol injection	—

Countries

Japan

Contacts

Public ContactAtsuo Yamada

University of Tokyo Department of Gastroenterology

yamada-a@umin.ac.jp+81338155411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026